Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Fauna Bio Lands $9M Seed Round

2021-09-21
EMERYVILLE, CA, Fauna Bio, a biotechnology company leveraging animal genomics to improve human health, has raised $9 million in Seed funding.
The round was led by LifeForce Capital, with participation from True Ventures, Boom Capital, Pacific 8 Ventures, BioMed Ventures, Vibe Capital and Arcadia Science. Fauna Bio will use the new funds to expand its drug discovery platform Convergence while accelerating the discovery of new therapeutic targets for human diseases across a broad range of indications.

Fauna Bio is developing new ways to treat human diseases, such as cardiovascular, fibrotic, metabolic and neurodegenerative diseases, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors